Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001615774-17-004877
Filing Date
2017-08-31
Accepted
2017-08-31 09:19:21
Documents
8
Period of Report
2017-08-31

Document Format Files

Seq Description Document Type Size
1 FORM 6-K s107389_6k.htm 6-K 13090
2 EXHIBIT 99.1 s107389_ex99-1.htm EX-99.1 377852
3 GRAPHIC img006_v1.jpg GRAPHIC 5963
4 GRAPHIC img001_v1.jpg GRAPHIC 45865
5 GRAPHIC img002_v1.jpg GRAPHIC 34750
6 GRAPHIC img003_v1.jpg GRAPHIC 64678
7 GRAPHIC img004_v1.jpg GRAPHIC 5240
8 GRAPHIC img005_v1.jpg GRAPHIC 10228
  Complete submission text file 0001615774-17-004877.txt   622370
Mailing Address 62 LYGON STREET LEVEL 3 CARLTON, VICTORIA C3 3053
Business Address 62 LYGON STREET LEVEL 3 CARLTON, VICTORIA C3 3053 61 03 9824 5254
Immuron Ltd (Filer) CIK: 0001660046 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-38104 | Film No.: 171062198
SIC: 2834 Pharmaceutical Preparations